TGFβ has been shown to promote epithelial-to-mesenchymal transition (EMT) in mammary epithelial cells [63], and therefore, it is plausible that inhibiting TGFβ signaling reduces EMT, and the invasive traits associated with it, in DCIS-like cancer cell cultures. Here, TGFB1 is linked to ductal breast carcinoma in situ.